Підписатись
Stefano Ballestri
Stefano Ballestri
Azienda USL Modena, Pavullo Hospital
Підтверджена електронна адреса в ausl.mo.it - Домашня сторінка
Назва
Посилання
Посилання
Рік
Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps
A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ...
Hepatology 70 (4), 1457-1469, 2019
8392019
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome
A Lonardo, S Ballestri, G Marchesini, P Angulo, P Loria
Digestive and Liver disease 47 (3), 181-190, 2015
8252015
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and …
S Ballestri, S Zona, G Targher, D Romagnoli, E Baldelli, F Nascimbeni, ...
Journal of gastroenterology and hepatology 31 (5), 936-944, 2016
7902016
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes
M Ricchi, MR Odoardi, L Carulli, C Anzivino, S Ballestri, A Pinetti, ...
Journal of gastroenterology and hepatology 24 (5), 830-840, 2009
7472009
NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk
S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ...
Advances in therapy 34, 1291-1326, 2017
5632017
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ...
Digestive and Liver Disease 47 (12), 997-1006, 2015
5322015
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
S Ballestri, A Lonardo, S Bonapace, CD Byrne, P Loria, G Targher
World journal of gastroenterology: WJG 20 (7), 1724, 2014
3612014
Nonalcoholic fatty liver disease and aging: epidemiology to management
M Bertolotti, A Lonardo, C Mussi, E Baldelli, E Pellegrini, S Ballestri, ...
World journal of gastroenterology: WJG 20 (39), 14185, 2014
3462014
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
E Villa, R Critelli, B Lei, G Marzocchi, C Cammà, G Giannelli, P Pontisso, ...
Gut 65 (5), 861-869, 2016
2582016
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD
S Ballestri, A Lonardo, D Romagnoli, L Carulli, L Losi, CP Day, P Loria
Liver International 32 (8), 1242-1252, 2012
2292012
Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications
C Tana, S Ballestri, F Ricci, A Di Vincenzo, A Ticinesi, S Gallina, ...
International journal of environmental research and public health 16 (17), 3104, 2019
2032019
The independent predictors of non‐alcoholic steatohepatitis and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alanine …
S Ballestri, F Nascimbeni, D Romagnoli, A Lonardo
Hepatology Research 46 (11), 1074-1087, 2016
1642016
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
P Loria, G Marchesini, F Nascimbeni, S Ballestri, M Maurantonio, ...
Atherosclerosis 232 (1), 99-109, 2014
1532014
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV
A Lonardo, S Ballestri, G Guaraldi, F Nascimbeni, D Romagnoli, S Zona, ...
World journal of gastroenterology 22 (44), 9674, 2016
1452016
Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease
A Mantovani, S Ballestri, A Lonardo, G Targher
Digestive diseases and sciences 61, 1246-1267, 2016
1392016
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases
S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ...
Metabolism 72, 57-65, 2017
1382017
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications
S Ballestri, D Romagnoli, F Nascimbeni, G Francica, A Lonardo
Expert review of gastroenterology & hepatology 9 (5), 603-627, 2015
1322015
Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen
A Lonardo, LE Adinolfi, L Restivo, S Ballestri, D Romagnoli, E Baldelli, ...
World journal of gastroenterology: WJG 20 (23), 7089, 2014
1202014
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?
L Carulli, S Ballestri, A Lonardo, F Lami, E Violi, L Losi, L Bonilauri, ...
Internal and emergency medicine 8, 297-305, 2013
1192013
the metabolic syndrome and non‐alcoholic fatty liver disease
P Loria, A Lonardo, L Carulli, AM Verrone, M Ricchi, S Lombardini, ...
Alimentary pharmacology & therapeutics 22, 31-36, 2005
992005
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20